Tag: article

ROAD TOWN, British Virgin Islands, Aug. 02, 2025 (GLOBE NEWSWIRE) -- The recent Ethereum bull run has renewed momentum across the blockchain space, drawing increased attention to emerging platforms that combine utility with innovation. Among them, Ozak AI is gaining investor interest as it announces the launch of Stage 4 of its $OZ token presale, now priced at $0.005.

LUXEMBOURG , Aug. 02, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift, a blockchain protocol combining Proof-of-Work (PoW), Proof-of-Stake (PoS), and an AI-powered Proof-of-Yield (PoY) mechanism, has officially entered Stage 3 of its presale. The platform is offering tokens at $3 during this limited 64-day window, with a scheduled increase to $4 in the next stage and a confirmed launch price of $15.

SINGAPORE, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ostium, a decentralized trading platform, has announced the launch of a new leveraged trading instrument: 0DTE perpetuals for equities. The instrument combines intraday expiry with perpetual structure, offering day traders up to 100x leverage on individual stocks during market hours — a structural innovation aimed at addressing the limitations of traditional options and CFDs.

ROAD TOWN, British Virgin Islands, Aug. 01, 2025 (GLOBE NEWSWIRE) -- OZAK AI has made a significant impact in the crypto and AI investment sector. It is capturing serious attention after completing its Certik audit (considered to be the best benchmark of security in blockchain projects worldwide) and raising over $1.5 million, with its presale ongoing, at just $0.005 per token.

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025

Information relative au nombre total des droits de vote et
d’actions composant le capital social au 31 juillet 2025

PANAMA CITY, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Gate US, the localized platform powered by global crypto leader Gate Group, has officially launched in the United States, now offering spot trading services tailored for U.S. customers. With a focus on security, simplicity, and regulatory compliance, Gate US aims to provide a seamless crypto trading experience supported by world-class infrastructure and trusted industry expertise.

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.¹ Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.

Transaction in Own Shares   

Nanterre, le 1^er août 2025